Edwards Lifesciences Corporation’s $600 Million Notes Offering

Cahill represented the underwriters in connection with a public offering of $600,000,000 aggregate principal amount of 4.300% senior notes due 2028 by Edwards Lifesciences Corporation.

Edwards Lifesciences Corporation is a medical equipment company specializing in hemodynamic monitoring and artificial heart valves.

Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC acted as underwriters on the offering.

Proceeds from the offering were used to refinance existing indebtedness and for general corporate purposes.

O’Melveny & Myers LLP advised Edwards Lifesciences Corporation.

Cahill advised the underwriters with a team including William J. Miller (Picture), Alla Digilova and Jana L. Douglas.

Involved fees earner: William Miller – Cahill Gordon & Reindel; Alla Digilova – Cahill Gordon & Reindel; Jana Douglas – Cahill Gordon & Reindel;

Law Firms: Cahill Gordon & Reindel;

Clients: Merrill Lynch, Pierce, Fenner & Smith Incorporated; JP Morgan Securities;


Author: Ambrogio Visconti